Australia Patent: Sanofi Biotechnology, Regeneron Pharmaceuticals File Application for 'Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist'

  • Meagan P. O'Brien

Press/Media

Period7 Jan 2022

Media coverage

1

Media coverage

  • TitleAustralia Patent: Sanofi Biotechnology, Regeneron Pharmaceuticals File Application for 'Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date7/01/22
    PersonsMeagan P. O'Brien
View all 1
View less